Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

BACKGROUND: Multiple sclerosis (MS) is a chronic disease that may require decades of ongoing treatment. Therefore, the long-term safety and efficacy of disease-modifying therapies is an important consideration. METHODS: The LONGTERMS study evaluated the safety and efficacy of fingolimod in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Jeffrey A., Tenenbaum, Nadia, Bhatt, Alit, Zhang, Ying, Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763939/
https://www.ncbi.nlm.nih.gov/pubmed/31598139
http://dx.doi.org/10.1177/1756286419878324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763939/
https://www.ncbi.nlm.nih.gov/pubmed/31598139
http://dx.doi.org/10.1177/1756286419878324

Ejemplares similares